ACTRN12607000321448.
Methods | Randomised placebo controlled trial. |
Participants |
Location: Australia. Single centre. Setting of recruitment and treatment: WA Centre for Health & Ageing, University of Western Australia. Inclusion criteria:
Exclusion criteria:
|
Interventions |
Intervention : 1000 IU vitamin D daily by oral tablet. Comparator group: Placebo (soyabean oil tablet indistinguishable from active tablet). |
Outcomes |
Outcomes of interest in the review: Overall cognitive functioning: Cambridge Examination for Mental Disorders in the Elderly ‐ Cognitive section (CAMCOG); Specific cognitive functioning subdomain: executive function: digit‐symbol coding task; Specific cognitive functioning subdomain: episodic memory: California Verbal Learning Scale‐Revised; Development of dementia; Quality of life: SF‐12. |
Reason awaiting classification | Only publication of baseline results and protocol found. No results available after contact with authors. |
Notes | National Health and Medical Research Council Dementia Research Grants Program |